-
81
Human African trypanosomiasis research gets a boost: unraveling the tsetse genome.
Published 2014-04-01Get full text
Article -
82
Early prediction of treatment efficacy in second-stage gambiense human African trypanosomiasis.
Published 2012-01-01“…BACKGROUND: Human African trypanosomiasis is fatal without treatment. The long post-treatment follow-up (24 months) required to assess cure complicates patient management and is a major obstacle in the development of new therapies. …”
Get full text
Article -
83
The structure of serum resistance-associated protein and its implications for human African trypanosomiasis
Published 2018“… <p>Only two trypanosome subspecies are able to cause human African trypanosomiasis. To establish an infection in human blood, they must overcome the innate immune system by resisting the toxic effects of trypanolytic factor 1 and trypanolytic factor 2. …”
Journal article -
84
Pathogenicity and virulence of African trypanosomes: From laboratory models to clinically relevant hosts
Published 2023-12-01Subjects: Get full text
Article -
85
-
86
Gambian human African trypanosomiasis in North West Uganda. Are we on course for the 2020 target?
Published 2019-08-01“…In 1994, combined active and passive screening reported 1469 cases from the historic Gambian Human African Trypanosomiasis (gHAT) foci of West Nile, Uganda. …”
Get full text
Article -
87
Eliminating human African trypanosomiasis: where do we stand and what comes next?
Published 2008-02-01Get full text
Article -
88
-
89
The Atlas of human African trypanosomiasis: a contribution to global mapping of neglected tropical diseases
Published 2010-11-01“…<p>Abstract</p> <p>Background</p> <p>Following World Health Assembly resolutions 50.36 in 1997 and 56.7 in 2003, the World Health Organization (WHO) committed itself to supporting human African trypanosomiasis (HAT)-endemic countries in their efforts to remove the disease as a public health problem. …”
Get full text
Article -
90
Healthcare Management of Human African Trypanosomiasis Cases in the Eastern, Muchinga and Lusaka Provinces of Zambia
Published 2022-09-01Subjects: “…human African trypanosomiasis…”
Get full text
Article -
91
Development of Reduced Peptide Bond Pseudopeptide Michael Acceptors for the Treatment of Human African Trypanosomiasis
Published 2022-06-01“…Human African Trypanosomiasis (HAT) is an endemic protozoan disease widespread in the sub-Saharan region that is caused by <i>T. b. gambiense</i> and <i>T. b. rhodesiense</i>. …”
Get full text
Article -
92
SCYX-7158, an orally-active benzoxaborole for the treatment of stage 2 human African trypanosomiasis.
Published 2011-06-01“…<h4>Background</h4>Human African trypanosomiasis (HAT) is an important public health problem in sub-Saharan Africa, affecting hundreds of thousands of individuals. …”
Get full text
Article -
93
Prevalence of dermal trypanosomes in suspected and confirmed cases of gambiense human African trypanosomiasis in Guinea.
Published 2024-08-01“…The skin is an anatomical reservoir for African trypanosomes, yet the prevalence of extravascular parasite carriage in the population at risk of gambiense Human African Trypanosomiasis (gHAT) remains unclear. Here, we conducted a prospective observational cohort study in the HAT foci of Forecariah and Boffa, Republic of Guinea. …”
Get full text
Article -
94
Incorporating scale dependence in disease burden estimates: the case of human African trypanosomiasis in Uganda.
Published 2014-02-01“…We mapped spatial variation in the burden of human African trypanosomiasis (HAT) in Uganda for the years 2000-2009. …”
Get full text
Article -
95
Focus-specific clinical profiles in human African Trypanosomiasis caused by Trypanosoma brucei rhodesiense.
Published 2010-12-01“…Diverse clinical features have been reported in human African trypanosomiasis (HAT) foci caused by Trypanosoma brucei rhodesiense (T.b.rhodesiense) giving rise to the hypothesis that HAT manifests as a chronic disease in South-East African countries and increased in virulence towards the North. …”
Get full text
Article -
96
Quantifying epidemiological drivers of gambiense human African Trypanosomiasis across the Democratic Republic of Congo.
Published 2021-01-01“…Gambiense human African trypanosomiasis (gHAT) is a virulent disease declining in burden but still endemic in West and Central Africa. …”
Get full text
Article -
97
Candidate genes-based investigation of susceptibility to Human African Trypanosomiasis in Côte d'Ivoire.
Published 2017-10-01“…Human African Trypanosomiasis (HAT) or sleeping sickness is a Neglected Tropical Disease. …”
Get full text
Article -
98
Development of a safer laboratory vervet monkey model for the study of human African trypanosomiasis
Published 2014-10-01“…Identifying an animal model of T. b. brucei that mimics human African trypanosomiasis (HAT) would enable researchers to study HAT without subjecting themselves to undue risks such as accidental infection. …”
Get full text
Article -
99
Melarsoprol cyclodextrin inclusion complexes as promising oral candidates for the treatment of human African trypanosomiasis.
Published 2011-09-01“…Human African trypanosomiasis (HAT), or sleeping sickness, results from infection with the protozoan parasites Trypanosoma brucei (T. b.) gambiense or T. b. rhodesiense and is invariably fatal if untreated. …”
Get full text
Article -
100
The genome sequence of Trypanosoma brucei gambiense, causative agent of chronic human african trypanosomiasis.
Published 2010-04-01“…Trypanosoma brucei gambiense is the causative agent of chronic Human African Trypanosomiasis or sleeping sickness, a disease endemic across often poor and rural areas of Western and Central Africa. …”
Get full text
Article